announcements 8 number 143 may 2009 the tri-monthly ...clinical pearls session, more than 400...

More than 1700 colleagues from 52 countries came together in Orlando, Florida, at the 2009 ACCP/ESCP International Congress on Clinical Pharmacy.

From April 24 to April 28, attendees exchanged information about best practices and discussed hot topics in the global health care arena.

The Congress agenda included core curricular programming, cutting-edge plenary sessions, and unique workshops on some of today’s most important health care topics:

• Technology and Medication Safety,

• Complementary and Alternative Medications,

• Impact of Pharmacogenomics and Culture on Medication Use and Safety,

• Medication Error Assessment and Strategies for Error Prevention.

In addition to the curricular track programs and workshops, meeting registrants took advantage of ACCP PRN/ESCP SIG-developed programs, networking events, a special global clinical pearls session, more than 400 research posters and platform presentations, and the ACCP Pharmacotherapy Preparatory Course.

Attendees also participated in the International Pediatric Pharmacy and Clinical Pharmacology Symposium, presented by the Pediatric Pharmacy Advocacy Group (PPAG).

The PPAG symposium featured many of today’s leading pediatric pharmacology cl in ic ians and researchers. We were gratified by the large number of practitioners, educators, researchers, residents/fellows, and students who attended the Congress.

Thanks to the leadership of those ESCP and ACCP members who served on the Organizing and Scientific Program committees, this exceptional conference will long be remembered by virtually all who were able to attend.

Michael S. Maddux, Michael S. Maddux, Michael S. Maddux, Michael S. Maddux,

Pharm.D., FCCP Executive Director, ACCP

[email protected]

The tri-monthly newsletter of the European Society

of Clinical Pharmacy News

E u r o p e a n S o c i e t y o f C l i n i c a l P h a r m a c y The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by society.society.society.society.

ESCP News

ESCP News

ESCP News

ESCP News �� May 2009

May 2009

May 2009

May 2009 �� Number 143

Number 143

Number 143

Number 143 �� ISSN 135

ISSN 135

ISSN 135

ISSN 13533 33-- -- 0321

0321

0321

0321

A Few Words

1

3333rdrdrdrd ACCP/ESCP ACCP/ESCP ACCP/ESCP ACCP/ESCP

International Congress International Congress International Congress International Congress on Clinical Pharmacy on Clinical Pharmacy on Clinical Pharmacy on Clinical Pharmacy

a Rousing Successa Rousing Successa Rousing Successa Rousing Success

ContentsContentsContentsContents : A Few words 1 ESCP life 2 Articles & Reports 5 Announcements 8

ESCP News

ESCP News

ESCP News


May 2009

May 2009


Number 143

Number 143


ISSN 135

ISSN 135

ISSN 13533 33-- -- 0321

0321

0321

0321

ESCP life

2

Louise received her bachelor in phar-macy for Dalhousie University in Hali-fax, Nova Scotia in Canada. She then did her residency in hospital pharmacy in Alberta- western Canada. After a few years of experience in hospital and community practice, she obtained a

Doctor of pharmacy degree from Mas-sachusetts College of Pharmacy in Boston. Finally, Louise found her ideal practice, geriatrics. She found a « role model » in geriatrics and did a two-year fellowship program in geriatrics at the

University of Athens, in Georgia, USA. She is currently professor in clinical pharmacy at the Faculty of Pharmacy at the University of Montreal and a clinical pharmacist at McGill University Health Center. She is the clinical phar-macist on an in-patient geriatric unit. She is responsible to provide pharma-ceutical care to 25 patients in an inter-disciplinary approach. She also pro-vides consultation to long-term care patients and to the consult geriatric team in the hospital. Louise has authored of two books in geriatrics and has authored or co-authored more than two dozen book chapters and close to 150 articles for refereed and professional journals. Dr. Mallet has received research funding to investigate such topics as reducing medication-related falls and training

caregivers for the elderly. She is cur-rently involved in evaluating if drug interactions are responsible for reason for admission for patients on the geri-atric unit. One of her special interest is abuse of elderly patients. She is currently working on an article on “Preventing abuse in elderly patient with Alzheimer’s disease”.

Louise took over the SIG in geriatrics a few years ago. It has been very stimu-lating to work with pharmacists all around the world to promote the geri-atric cause. She has been involved in the presentation of many workshops at every ESCP conference. The next step is to start a « common » research project for geriatric patients around the world.

Louise Mallet Louise Mallet Louise Mallet Louise Mallet

[email protected]

Special Subscription Rates for Adis Journals Special Subscription Rates for Adis Journals Special Subscription Rates for Adis Journals Special Subscription Rates for Adis Journals Available to ESCP MembersAvailable to ESCP MembersAvailable to ESCP MembersAvailable to ESCP Members

Who’s Who: Louise MalletWho’s Who: Louise MalletWho’s Who: Louise MalletWho’s Who: Louise Mallet Chair of the SIG in GeriatricsChair of the SIG in GeriatricsChair of the SIG in GeriatricsChair of the SIG in Geriatrics

As a benefit of ESCP membership, Wolters Kluwer Health | Adis are pleased to offer ESCP members discounted personal sub-scription rates to several of its prestigious journals. Adis' journals are among the most-cited publications in their respective fields, and provide a unique blend of original articles and authoritative reviews, drug profiles and evaluations.

Peer-reviewed by international opinion leaders, these journals provide independ-ent, objective and crucial information on all aspects of drug development, clinical phar-macology, pharmacoeconomics and dis-ease management. Personal print and online subscription allows online access to full-text articles from current content plus the extended back file (dating from 1998 for most journals).

Drugs & Therapy Perspectives is a concise, authoritative aid to drug decision making. It is an essential publication for pharmacists and physicians who need to make formu-lary and prescribing decisions. The journal provides the latest clinical and drug knowl-edge presented in an easy-to-read format.

Dedicated to improving the effective and safe use of drugs in neonates, children and adolescents, Pediatric Drugs provides leading current opinion articles on conten-tious and emerging issues and definitive reviews of topics relating to the effective and safe use of drug therapy in a range of specific disorders and through all stages of paediatric development.

ESCP members will receive discounted rates on subscriptions to the following journals:

US$99/€75 per subscription to: (full rate- US$199) - Drugs & Therapy Perspectives - Pediatric Drugs

US$179 per subscription to: (full rate- US$199) - Drugs & Aging

US$225 per subscription to: (full rate- US$250) - Clinical Pharmacokinetics - Drug Safety - Pharmacoeconomics

To qualify for your reduced rates, please visit the members only area at the ESCP website (www.escpweb.org)

Erik GerbrandsErik GerbrandsErik GerbrandsErik Gerbrands ESCP Secretary-Treasurer

[email protected]

ESCP SIG GeriatricsESCP SIG GeriatricsESCP SIG GeriatricsESCP SIG Geriatrics

The SIG Geriatrics presents a new clinical case (see ESCP News 142). The SIG Geriatrics presents a new clinical case (see ESCP News 142). The SIG Geriatrics presents a new clinical case (see ESCP News 142). The SIG Geriatrics presents a new clinical case (see ESCP News 142). If you cannot find the answer … see on page 4.If you cannot find the answer … see on page 4.If you cannot find the answer … see on page 4.If you cannot find the answer … see on page 4.

An 85-year-old woman presents to the E.R. with nausea, vomiting, confusion and general deterioration. Her husband reports that she had been getting progressively worse over the past week.

The patient is known to have significant cog-nitive impairment and her husband assists her with many of her activities of daily living. When she is at her best she is able to walk around their apartment while supervised.

Her medication history reveals the following:

Warfarin 2.5mg 1x /d Digoxin 0.25mg 1x /d Hydrochlorothiazide 50mg 1x/d Levothyroxine 0.05mg 1x/d Glyburide 10mg 2x/d Metformin 500mg 3x/d Sotalol 80mg 2x/d Alendronate 70mg every Sunday Calcium carbonate 500mg 2x/d Pantoprazole 40mg 1x/d Gabapentin 600mg 3x/d Multivitamin 1x/d

Her known medical conditions include: type 2 diabetes, hypothyroidism, hypertension, atrial fibrillation, stroke, and a moderate vascular dementia (Folstein MMSE 18/30) ; weight 49.5kg, BP 90/65mmHg, P 40 irreg ; Aller-gies: sulfa drugs ; Abnormal labs: INR 5.3 (therapeutic range 2.0-2.5) ; Serum digoxin level 2.24 nmol/L (therapeutic 1.0) ; Calcu-lated creatinine clearance = 21ml/min Na 130 mmol/L

What would you do for this patient?

ESCP News

ESCP News

ESCP News


May 2009

May 2009


Number 143

Number 143


ISSN 135

ISSN 135

ISSN 13533 33-- -- 0321

0321

0321

0321

ESCP life

3

Based on the nominations received until the deadline 31 March 2009 (see ESCP News Number 139, p.3), the General Committee (GC) of the ESCP at its recent meeting in Orlando decided on the first members to be recognized as ESCP fellows. The selected persons will be awarded on 4 November 2009 during the opening ceremony at the coming ESCP symposium in Geneva. Fellowship is awarded in recognition of continued excellence in clinical pharmacy practice and/or research, contribution to the advancement of clinical pharmacy,

preferably in Europe, and services for ESCP. Nominees must have been a full member of ESCP for at least 5 years; must have been in practice for at least 5 years since receipt of their highest professional pharmacy degree; and must have made a substantial and sustained contribution to ESCP through activities such as presentation at conferences, symposia, and/or meetings; service to ESCP committees, SIGs, or publications; or election as an officer. Current GC members, however, are not eligible.

The next Fellows will be awarded during the ESCP symposium in 2010. So, please email your nominations in the required format, as stated under 11. a) – c) below, before 31 March 2010 to: The President of ESCP Frank Jørgensen frank.jorgensen@ apotekene-vest.no. A nomination committee will then propose eligible colleagues for decision within the GC.

Martin SchulzMartin SchulzMartin SchulzMartin Schulz Member of the GC for Germany

[email protected]

GC decided on first members to be GC decided on first members to be GC decided on first members to be GC decided on first members to be recognized as ESCP Fellows (FESCP)recognized as ESCP Fellows (FESCP)recognized as ESCP Fellows (FESCP)recognized as ESCP Fellows (FESCP)

As President of ESCP I was invited to attend the DUPHAT conference in March in Dubai. The Dubai International Pharma-ceuticals and Technologies Conference and Exhibition (DUPHAT) is an annual event established in 1995. It is arranged under the patronage of the Dubai Health Authority and chaired by Dr. Ali Al Sayed Hussain. The delegates come from all over the Arabian world including phar-macy students from the universities based in the United Arab Emirates. There is a large commercial exhibition and the conference is academically supported by ten universities and pharmaceutical asso-ciations from Europe, USA, Canada and Australia, among them Utrecht University, the University of Leeds, Monash Univer-sity in Australia, ASHP, ESOP and ESCP.

The scientific programme consists of plenary lectures, oral presentations, work-shops and a poster session including a large number of student posters. This year the main themes were Research and Leadership in Pharmacy Practice, Phar-macy Practice, Pharmacogenomics, Qual-ity Measurement, Antimicrobial Steward-ship and Health Tourism. There was also a session on Pharmacovigilance and Pharmacoepidemiology. There was a mix of western and local lecturers and pre-

senters, something which fostered good cross-fertilisation of knowledge and skills.

It is rewarding to be a part of such a cross-cultural event. One tends perhaps to think that the pharmaceutical challenges facing the health systems of the Middle Eastern countries are different to the ones in Europe. That might indeed be so, but I think we have much common ground to cover. To me, this became especially evident in the workshop I held on patient

education. The 50 male and female par-ticipants came from Oman, Egypt, the Emirates and other countries. In the out-set I therefore was a bit worried that a patient case “from the West” would be hard for the participants to engage in. This turned out not to be the case! I soon discovered that even if the culture may be different, we deal with the same issues with regard to compliance and concor-dance. Consequently, there was a lot of discussion regarding how best to educate and communicate with the patients.

Another feature is the pioneering spirit of the conference. This became evident to me through the assessment of the student posters. Each of the foreign academic con-tributors was given a set of posters to as-sess. The themes included patient safety, medicines information, quality assurance and others. Apart from the many good qual-ity posters, what impressed me was the sincere enthusiasm, pride and professional-ism the students presented their work with. They came across as people with a strong vocation towards developing pharmacy towards ever higher standards.

The closing ceremony turned out to be a two hour celebration of pharmacy with the awarding of the best student oral presenta-tion and best student poster as the high points. The lucky winners were truly cele-brated with a level of cheering and support from the audience I have seldom or ever witnessed, at least in an academic setting.

In summary; I left Dubai with high hopes for the future of pharmacy! Please take a look at www.duphat.ae. for information on the proceedings of the 2009 conference and the plans for 2010.

Frank JørgensenFrank JørgensenFrank JørgensenFrank Jørgensen President ESCP

[email protected]

1. Fellowship is awarded in recognition of continued excellence in clini-cal pharmacy practice and/or research. 2. Nominees must have been a full member of ESCP for at least 5 years; must have been in practice for at least 5 years since receipt of their highest professional pharmacy degree; and must have made a sustained contribution to ESCP through activities such as presentation at conferences/symposia/meetings; service to ESCP commit-tees, SIGs, or publications; or election as an officer. 3. Qualifying nominations for ESCP Fellow candidates must be cast by two Full Members or any Fellow, GC member or any RESC chair. 4. The ESCP GC decides on the nomination by a majority of votes. 5. The successful candidate(s) will be recognized during the ESCP fall conferences and announced in ESCP News. 6. A list of fellows will be made available at the ESCP homepage. 7. Travel costs of the successful candidate(s) to attend the awarding ceremony shall not be reimbursed by ESCP. 8. The successful candidate receives a plaque in recognition and may use the designation "FESCP".

9. An ESCP Fellow, who, subsequent to receiving the award, ceases to be an ESCP Individual Member, may not continue to use the designa-tion FESCP. 10. Unsuccessful candidates may be re-nominated, provided all criteria are still met at the time of re-nomination. 11. Nominations should be submitted to the ESCP president before the 31 March of the year in which the award will be presented, and should contain the following information: a) Curriculum Vitae of the candidate (in English, not exceeding two A4/letter pages, sent by e-mail); b) A statement of the reasons why the candidate has been nominated (in English, not exceeding two A4/letter pages, sent by e-mail), utilizing the following headings: I . Continued excellence in clinical pharmacy practice and/or research (including a list of - selected/most recent - peer-reviewed publications in the field of clinical pharmacy) II . Contribution to the advancement of Clinical Pharmacy (preferable in Europe) III . Services to ESCP c) Name, address, e-mail, fax and telephone number of the nominee.

ESCP Fellows Criteria ESCP Fellows Criteria ESCP Fellows Criteria ESCP Fellows Criteria

Report from the Duphat conference Report from the Duphat conference Report from the Duphat conference Report from the Duphat conference in Dubai 29in Dubai 29in Dubai 29in Dubai 29----31 March 200931 March 200931 March 200931 March 2009

Remaining life expectancy for this Remaining life expectancy for this Remaining life expectancy for this Remaining life expectancy for this patient patient patient patient = 2 years Time to benefit from her medications Time to benefit from her medications Time to benefit from her medications Time to benefit from her medications for the different disease states:for the different disease states:for the different disease states:for the different disease states: Blood pressure, diabetes => 10 years

Warfarin => 1 year

Alendronate => 1-3 years for vertebral fractures

Goals of care:Goals of care:Goals of care:Goals of care: Maximize quality of life, symptoms control.

Return patient home if possible.

Reduce medications and side effects.

Treatment targetsTreatment targetsTreatment targetsTreatment targets Warfarin: - Discontinue for 2 days; INR then adjust according to INR. - Continue: warfarin (with monitoring).

Discontinue: Digoxin, pantoprazole, gabapentin, alendronate, multivitamin Decrease: Sotalol 40mg bid. Add: Vitamin D 10,000 units q week.

Discontinue: Glyburide and metformin. Add: Gliclazide 40 mg 2 x/d and adjust according to blood glucose.

Discontinue: Hydrochlorothiazide: patient has a low sodium; by discontinuing hydro-chlorothiazide sodium should get back to normal by the end of 1st week.

ESCP News

ESCP News

ESCP News


May 2009

May 2009


Number 143

Number 143


ISSN 135

ISSN 135

ISSN 13533 33-- -- 0321

0321

0321

0321

ESCP life

4

As we experienced various problems to transfer our banking account and to setup the online payment platform, we did not send any reminder for 2008. We are happy to inform you that our new online payment platform has been successfully tested by members of the General Com-mittee (GC). We are now reviewing their comments and, after a few last improvements, the payment platform will be available. As an ESCP member, you will be able not only to renew your membership (figure 1) but also to edit your profile or update your member-ship in various Special Interest Groups SIG (figure 2). Dual members (e.g. of the SIFO or SFPC) will continue to renew their mem-bership within their national societies. New members will also be able to apply online.

We encourage you to continue choosing ESCP as your professional resource and network. ESCP is dedicated to encouraging the professional development and educa-tion of Clinical Pharmacists across Europe. As a member you will receive a personal-ised e-mail with your password inviting you to pay your membership fees for either 1, 2, 3 or 5 years and continue receiving benefits from your membership such as the ESCP newsletter, PWS and its online access, discount registration to ESCP sym-posia, discount prices on selected Adis publications.

In May, members who could not pay their membership for 2008 will be offered the following opportunities: 2 years Full Membership (2008-2009): => € 138

3 years Full Membership (2008-2010): => € 169 (saving of 38 €) 5 years Full Membership (2008-2012): => € 269 (saving of 76 €)

Then, in June, the members who have paid until 2009 will receive a personalised e-mail with their password to renew their membership for 1, 3 or 5 years. And from June on, new members will be able to apply online. As we are convinced of the strategic role of our website this is a first step that will opti-mise relationships between members and the International Office and it will definitely not be the last...

Johnny Beney Johnny Beney Johnny Beney Johnny Beney ESCP webmaster,

ESCP General Committee member, [email protected]

What’s new on What’s new on What’s new on What’s new on www.escpweb.orgwww.escpweb.orgwww.escpweb.orgwww.escpweb.org ? ? ? ?

ESCP SIG GeriatricsESCP SIG GeriatricsESCP SIG GeriatricsESCP SIG Geriatrics Answer of the clinical case (page 2)Answer of the clinical case (page 2)Answer of the clinical case (page 2)Answer of the clinical case (page 2)

Figure 1

Figure 2

ESCP News

ESCP News

ESCP News


May 2009

May 2009


Number 143

Number 143


ISSN 135

ISSN 135

ISSN 13533 33-- -- 0321

0321

0321

0321

Articles & Reports

5

ACCP/ESCP International ACCP/ESCP International ACCP/ESCP International ACCP/ESCP International Congress on Congress on Congress on Congress on

Clinical PharmacyClinical PharmacyClinical PharmacyClinical Pharmacy Orlando, USA , 24Orlando, USA , 24Orlando, USA , 24Orlando, USA , 24----28 April 200928 April 200928 April 200928 April 2009

Personal NotePersonal NotePersonal NotePersonal Note On this my first visit to Orlando, Florida, I was overwhelmed by the grandness of everything. I knew they like to supersize things over there, but I still wasn’t prepa-red. The massive conference venue, the “light snacks” that would easily feed a small family, the hangar-like session rooms… But they managed to keep it real and relevant, and I had no problems focusing on the conference program. Quite the opposite – there was so much to choose from and you can only be in one place at a time.

When I first arrived I heard of the unba-lanced European / American atten-dance, approximately 1 to 7. This led me to expect that I would have a hard time finding familiar faces from previous ESCP conferences, but I was wrong. Partly because most American atten-dees were exclusively following the phar-macotherapy preparatory course running

alongside the entire conference, partly because the European version of clinical pharmacy is well advanced and has a lot to offer in a global perspective.

I always thought that clinical pharmacy in the USA was so far ahead of us that we could never catch up, but it turns out we’re on parallel tracks. Similarities and differences depending on our respective health care systems, cultural differences and professional opportunities make for

fruitful discussions and useful examples to ponder on in the quiet post confe-rence solitary.

I did spend 15 minutes by the pool on a couple of days, and I met some people who during their stay in Orlando had visited some sort of theme park nearby… My tourist experience of this trip is sadly limited to the spotting of exotic birds at the hotel pool area and the absolute explosions of Disney and Spiderman at the airport. But who am I to complain?

The joint ESCP ACCP conference gave me useful input, both professionally and personally and there will surely be ano-ther opportunity to visit Disney World, Waterworld, Universal Studios, Cape Canaveral, the Everglades…

Sara ClaessonSara ClaessonSara ClaessonSara Claesson [email protected]

Pediatric Pharmacy Advocacy Group (PPAG)Pediatric Pharmacy Advocacy Group (PPAG)Pediatric Pharmacy Advocacy Group (PPAG)Pediatric Pharmacy Advocacy Group (PPAG)

PPAG had a string of plenary sessions and workshops throughout the entire conference. The different topics span-ned from world-wide aspects of drug delivery to individual genetic variations causing unforeseen effect of medica-tion in small children.

We were all given a chance to unders-tand our different perspectives on health care in the world. The major killers in developing countries, such as malaria and diarrhoea, are not so hot topics for developed countries to do research in. And basic needs for suc-cessful drug treatment, such as clean water for admixtures or the access to cold storage, are oftentimes lacking. WHO have several projects to increase

successful drug therapy treatment in children, and some of them were pre-sented during the conference.

Pharmacogenomics with respect to children was another angle for the PPAG sessions. Both general develop-mental issues such as enzyme expres-sion that may vary depending on the age post conception or post partum of the child, and also individual variations that can make or break the intended drug therapy.

Health care issues may vary all over the world, but for our paediatric pa-tients one striking similarity became obvious during the sessions – the pro-blem with appropriate drug formula-

tions. It seems that no one claims ownership of that problem; hence the solutions are low on the list of priori-ties for all involved except for paedia-tric clinical pharmacists around the world…

Someone said that she was embarras-sed to tell the parents of her little pa-tients that it is possible to operate on tiny bodies but we cannot figure out how to get the proper drugs into them. No solutions surfaced during the four days, but hopefully our united voices and efforts can produce some pro-gress in the formulations area.


Patients around the world respond to drug treatment in different ways for va-rious reasons. It might be difficult to dissect why without slipping into political-ly incorrect explanations, but during the conference many of the speakers sho-wed that some answers might lie in well-accepted and obvious differences bet-ween people.

Advances in the pharmacogenomics area help us understand better why some people respond to a certain drug and some don’t. But other kinds of diffe-

rences may also play a part, differences perhaps not so obvious to a habitual scientist. For example the impact of faith and religious role models on the patient-’s decisions regarding their drug therapy. Who do they turn to for information, discussion and support?

Are some treatment options out of the question? With worldwide migration both patients and health care providers will sometimes work and live in unfamiliar communities and these questions need to be addressed. The Orlando confe-

rence certainly put some of them on the table.

Straight forward communication, profes-sional humility and a more humanistic approach to how big an impact the sug-gested drug therapy may have on the patient’s daily life will surely solve some of the problems. We all know never to assume anything about another person, but we all need to be reminded from time to time.


Pharmacogenomics and culturePharmacogenomics and culturePharmacogenomics and culturePharmacogenomics and culture

During the International Congress of the ACCP and ESCP in Orlando, the ‘Best Paper Award’ (a plaque and a price of $500) was given to Larissa H. Cavallari of the University of Illenois at Chicago, USA with paper # 96 entitled: ‘Genetic and clinical determinants of warfarin dose requirements in African Americans’.

There were two runners up. The first was Sandra Garner from the Medical University of South Carolina with a paper entitled: Effect of computerized prescriber order

entry with decision support in antibiotic errors in neonatal late onset sepsis. The other runner-up comes from Europe. Ulrika

Gillespie and Anna Alassaad from the Uni-versity of Uppsala in Sweden with paper #43 entitled ‘A comprehensive pharmacist intervention to reduce morbidity in patients aged 80 years or older: A randomized, controlled trial’.

ESCP wishes to congratulate all winners, but especially the Swedish team!

Foppe van MilFoppe van MilFoppe van MilFoppe van Mil [email protected]

ACCP educational programs are designed to meet members’ professional needs in achieving highest standards in clinical practice, education, leadership, and research.

The ACCP Academy is a multiyear profes-sional development program that offers members a flexible, curricular approach to enhancing their knowledge, skills, and abili-ties in their practice areas. The four unique Academy programs are Teaching and Learn-ing, Leadership and Management, Research and Scholarship, and Clinical Practice Ad-vancement (debut in fall 2009).

Each program consists of required and elec-tive course work delivered during ACCP’s spring and fall meetings. Participants reflect on their learning experiences using an online electronic portfolio. Program graduates re-ceive a certificate of completion and ACCP Academy recognition.

ACCP offers exceptional preparatory courses and unique programs for pharmacists pursu-ing certification or recertification in two phar-macy specialties: Board Certified Pharmaco-therapy Specialist (BCPS) and Board Certified Oncology Pharmacist (BCOP).

Updates in Therapeutics: the Pharmacother-apy Preparatory Course is designed for phar-macists who are pursuing certification as BCPSs. The program is offered live each year at ACCP's spring meeting. Course materials are also available in a variety of formats (online, print, and CD-ROM) for those seeking a self-paced comprehensive review and up-date of pharmacotherapeutics.

The Pharmacotherapy Self-Assessment Program (PSAP), approved for BCPS recerti-fication, is a series of eleven home study books. This valuable resource, available in print and online, provides subscribers with peer-reviewed contemporary appraisal of

topics related to the science and practice of pharmacotherapy. The program features web-based self-assessment questions and convenient online, evidence-supported answers. The seventh edition will be launched with the publication of book 1 (Cardiology) in January 2010.

Other educational programs featuring various content and instructional media are offered through-out the year. Informa-tion on ACCP’s latest professional develop-ment programs and publications is a v a i l a b l e a t www.accp.com.

Wafa Y. Dahdal, [email protected]

ESCP News

ESCP News

ESCP News


May 2009

May 2009


Number 143

Number 143


ISSN 135

ISSN 135

ISSN 13533 33-- -- 0321

0321

0321

0321

Articles & Reports

6

ACCP/ESCP International ACCP/ESCP International ACCP/ESCP International ACCP/ESCP International Congress on Congress on Congress on Congress on

Clinical PharmacyClinical PharmacyClinical PharmacyClinical Pharmacy Orlando, USA, 24Orlando, USA, 24Orlando, USA, 24Orlando, USA, 24----28 April 200928 April 200928 April 200928 April 2009

ACCP Research InstituteACCP Research InstituteACCP Research InstituteACCP Research Institute The ACCP Research Institute, a non-profit organization, is the research arm of the American College of Clinical Pharmacy. The mission of the ACCP Research Institute is to advance clinical pharmacy through support and promotion of research, training, and educational programs. The Frontiers Fund is the name of the ACCP Research Institute’s development campaign. Created in 2003, the fund has successfully raised and awarded more than $1 million in grants and program funding. The Frontiers Fund is the mechanism by which the Re-search Institute is able to meet the strategic goals of the Research Institute.

The overall goals for the Research Institute in 2009-2010 are as follows: - Develop the next generation of clinical phar-macy researchers through a variety of investi-gator development programs, such as the Focused Investigator Training (FIT) Program. – Create a substantial national clinical phar-

macy practice-based research network (ACCP PBRN).

ACCP PBRNACCP PBRNACCP PBRNACCP PBRN The Research Institute will create the first national clinical pharmacy practice-based research network (ACCP PBRN). Clinical pharmacists play an important role in our health care system by improving medication therapy management and decreasing ad-verse drug reactions for patients. Yet we have not systematically studied the services clinical pharmacists offer on a large scale. Through the ACCP PBRN, pharmacists and their prac-tice sites will have the opportunity to join forces and participate in practice-based stud-ies on a national scale.

Focused Investigator Training (FIT) ProgramFocused Investigator Training (FIT) ProgramFocused Investigator Training (FIT) ProgramFocused Investigator Training (FIT) Program The Focused Investigator Training Program is an intensive 1-week hands-on program held annually for up to 25 experienced pharma-cist-investigators who have not yet been

awarded significant peer-reviewed extramu-ral funding as a principal investigator. This new career development program, estab-lished by the ACCP Research Institute in 2008, provides an opportunity for experi-enced investigators to take necessary steps toward preparing a K, R01, or similar investi-gator-initiated application for submission to the NIH or other major funding source. The target audience is pharmacist-investigators with prior pilot research data wanting to cre-ate a focused competitive grant application that will support a significant extramural grant application. The Research Institute is continuing its com-mitment to uncompromising excellence in scholarship, education, and research while expanding the impact of clinical pharmacy professionals across the health care commu-nity. For more information on the programs and services of the Research Institute, please go to www.accpri.org.

ACCP Educational ProgramsACCP Educational ProgramsACCP Educational ProgramsACCP Educational Programs

Nick Barber

The 38th symposium of clinical pharmacy will be organized jointly the ESCP and the GSASA (Swiss Society of Public Health Administration and Hospital Pharmacists) in the CICG (International Conference Cen-tre Geneva) from Tuesday 3rd to Friday 6th November 2009.

Come and join us in Geneva ! After the opening lecture sched-uled on Tuesday evening Novem-ber 3rd, we will discuss and learn on Multidisciplinary Cooperation on Wednesday 4th, Patient Fo-cused Care on Thursday 5th and Integrating Technologies in our Work on Friday 6th.

During 3 days we will meet inter-national experts reporting on recent developments, exchange and share knowledge during workshops, oral communica-tions or poster sessions. More information will be avail-able soon on www.escpweb.org.

Registration openRegistration openRegistration openRegistration open

Abstracts submission Abstracts submission Abstracts submission Abstracts submission openopenopenopen

1st July 2009 Abstracts submission Abstracts submission Abstracts submission Abstracts submission

deadlinedeadlinedeadlinedeadline

31 July 2009 Early bird registration Early bird registration Early bird registration Early bird registration


23 October 2009 Late registration Late registration Late registration Late registration


30 Years of Clinical Pharmacy : A bright future30 Years of Clinical Pharmacy : A bright future30 Years of Clinical Pharmacy : A bright future30 Years of Clinical Pharmacy : A bright future ahead !ahead !ahead !ahead !

To learnlearnlearnlearn more more more more about the

programme and register, visitvisitvisitvisit:

www.escpweb.org or mail

[email protected]

In the last few years, Italy recognised the need to in-crease the value of the clinical pharmacist and improve the quality of patient care in the Italian Health System.

The Pharmacy of San Giovanni Battista Hospital in Turin is very active in this field: Silvana Stecca (Pharmacy director), Francesco Cattel and Annalisa Gasco will be organising an interesting conference: “The medical unit pharmacist: expectations and skills, models and results” that will be held on May 21 -22 in Turin (Lingotto Conven-tion Centre – Via Nizza, 280).

During the first day of the conference the European and International experiences will be presented: F. Jorgesen (ESCP president, Norway), R. Frontini (future EAHP presi-dent, Germany), J. Surugue (EAHP president, France), E. Azizi (USA) and A. Vulto (Netherland) are some of the

international speakers; the Italian experiences will be presented on the second day, including representatives from Institution, Universities and Scientific Societies.

The goal of the conference is identification, drawing motivation and inspiration from international models, to investigate the clinical dimension of our profession, and to consolidate the relevance of clinical pharmacist as providers of pharmaceutical care.

We hope that clinical pharmacists from European coun-tries attend the conference to know our reality, and to share their experience with their Italian colleagues.

Piera PolidoriPiera PolidoriPiera PolidoriPiera Polidori

General Committee ESCP member [email protected]

Joint meeting ESCPJoint meeting ESCPJoint meeting ESCPJoint meeting ESCP----SFPCSFPCSFPCSFPC Lyon, France, 21Lyon, France, 21Lyon, France, 21Lyon, France, 21----23 October 201023 October 201023 October 201023 October 2010

Organising Committee (OC)Organising Committee (OC)Organising Committee (OC)Organising Committee (OC) From SFPC Gilles Aulagner (President) Jean Calop Jean-Louis Prugnaud

From ESCP Marie-Caroline Husson Erik Gerbrands Frank Jorgensen

A local organising committee A local organising committee A local organising committee A local organising committee will help the OC.

Scientific Committee (SC)Scientific Committee (SC)Scientific Committee (SC)Scientific Committee (SC) From SFPC Benoit Allenet Olivier Bourdon Dominique Breilh Stéphane Honoré Pascal Le Corre Marie–Claude Saux

From ESCP Cecilia Bernsten Marcel Bouvy Vera von Gunten Foppe van Mil Moira Kinnear

A local scientific committee A local scientific committee A local scientific committee A local scientific committee will help the SC.

Italian pharmacists input on development of the pharmacist model in the medical unitItalian pharmacists input on development of the pharmacist model in the medical unitItalian pharmacists input on development of the pharmacist model in the medical unitItalian pharmacists input on development of the pharmacist model in the medical unit

2009200920092009

3333----6 November6 November6 November6 November

Geneva (Switzerland)

38th ESCP European Symposium on Clinical Pharmacy

2010201020102010

21212121----23 October23 October23 October23 October Lyon (France) 39th ESCP-SFPC European Symposium on Clinical Pharmacy

For Your DiaryFor Your DiaryFor Your DiaryFor Your Diary

ESSSSCP European Society of Clinical PharmacyEuropean Society of Clinical PharmacyEuropean Society of Clinical PharmacyEuropean Society of Clinical Pharmacy

ESCP News ESCP News ESCP News ESCP News is published by ESCP Editor: Marie Caroline Husson (France) Co-ordinator: Lilian M. Azzopardi (Malta) Page Lay-out: Corinne Tollier (France)

The contents of this publication are compiled in good faith. The publisher accepts no responsibility for omissions or errors.

ESCP International OfficeESCP International OfficeESCP International OfficeESCP International Office It Krúswâld Pharmacy—Voorstraat 13 NL-9285 NM Buitenpost—The Netherlands Tel: +31 645 915 831 Fax : +31 511 543 660 E-mail: [email protected] www.escpweb.org Deadline for the submission of material: for issue number 144 is 10 October 2009.

ESCP News

ESCP News

ESCP News


May 2009

May 2009


Number 143

Number 143


ISSN 135

ISSN 135

ISSN 13533 33-- -- 0321

0321

0321

0321

Announcements

8

New membersNew membersNew membersNew members

Belgium:Belgium:Belgium:Belgium: Isabel Spriet............................. Leuven

United Kingdom:United Kingdom:United Kingdom:United Kingdom: Antoniou Sotiris ...................... London

Attention!Attention!Attention!Attention!

• To nominate candidate for ESCP Fellows......see p. 3 • To become a ESCP Member ..........................see p. 4 www.escpweb.org

announcements 8 number 143 may 2009 the tri-monthly ...clinical pearls session, more than 400...

Documents